← All indications
Leiomyoma
A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.
Subtype terms (3)
More specific conditions that are subtypes of Leiomyoma in the MeSH hierarchy.
Drugs by status
Approved for this indication (1)
Phase 4 trials (24)
Phase 3 trials (17)
Phase 2 trials (10)
Phase 1 trials (12)
Organizations
Organization Involved with Phase 4 Indications (30)
- National Institutes of Health (NIH)
- Triệu, Nguyễn Thị, M.D.
- Aarhus University
- Maimonides Medical Center
- Mansoura University
- NHS Lothian
- Northwestern University
- University of Edinburgh
- University of Milan
- University of Toronto
- Mayo Clinic
- Peking University
- Tel Aviv University
- University of Cagliari
- University of California, Los Angeles
- University of California, San Francisco
- University of Chicago
- University of Turku
- Icahn School of Medicine at Mount Sinai
- University of Amsterdam
- Free University of Amsterdam
- Tran Minh Duc, Dr.
- Orebro University
- The University of Hong Kong
- Magna Graecia University
- University of Sao Paulo
- Regionshospitalet Horsens
- Chinese Academy of Medical Sciences
- China Resources Zizhu Pharmaceutical Co., Ltd.
- My Duc Phu Nhuan Hospital
Organization Involved with Phase 3 Indications (27)
- Abbott
- AbbVie
- Takeda
- Forest Laboratories
- Allergan
- Bayer
- Myovant Sciences GmbH
- ObsEva SA
- Ain Shams University
- Cairo University
- Eastern Virginia Medical School
- Makerere University
- Mediterranea Medica S. L.
- Mt. Hope Maternity Hospital
- Ilsan Hospital
- Royan Institute
- Seoul National University
- University of Miami
- University of Rochester
- University of Valencia
- Zagazig University
- Capital Medical University
- Cha Medical University
- Watson Pharmaceuticals
- Repros Therapeutics
- Gedeon Richter Ltd.
- Northern Ontario School of Medicine
Organization Involved with Phase 2 Indications (10)
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (10)